TWST (Twist Bioscience, Inc.) Asil keuangan resik

The Twist Bioscience (TWST) price chart on GURU.Markets illustrates a dominance strategy driven by low-cost chip-based gene synthesis. Twist Bioscience generates revenue through B2B DNA supplies for the agricultural and medical sectors, although the profit metric stands at -0.14. Financial pressure stems from aggressive capacity expansion, even though primary legal threats have been neutralized despite a potential decline in biomedical orders.

Investors assess business quality through the ability to generate free cash flow. This indicator captures the daily net margin by deducting all operating expenses from total revenue. For Twist Bioscience (TWST), this reflects the efficiency of scaling DNA synthesis and implementing data storage systems. The analysis reveals management's actual resilience to market shocks. By studying the company's profit dynamics, one can determine the optimal entry point without the risk of buying at the peak.